SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

HLS (HLS) News

Follow HLS (HLS) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 12 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol HLS Asset market Sector Markets 90 days 12 Updated Nov 12, 2026, 12:19 PM UTC Open live news feed
L HLS Sees 2026 Adjusted EBITDA in Lower Half of Guidance HLS Therapeutics expects 2026 adjusted EBITDA in the lower half of its $18.5 million-$21 million guidance range. EARNINGS | Nov 12, 2026, 12:19 PM UTC L Healius Target Price Cut 4.4% to A$0.43/Share by Macquarie>HLS.AU Healius Target Price Cut 4.4% to A$0.43/Share by Macquarie>HLS.AU NEWS | Sep 27, 2026, 11:35 PM UTC L Asian Shares Mixed In Thin Holiday Trade BEIJING (dpa-AFX) - Asian stocks ended mixed in thin trade on Friday, with markets in South Korea, Taiwan and mainland China closed for public holidays.The U.S. dollar consolidated weekly gains ahead of durable goods ord GEOPOLITICS | Sep 25, 2026, 08:54 AM UTC L Healius Target Price Raised 7.3% to A$0.44/Share by Jefferies>HLS.AU Healius Target Price Raised 7.3% to A$0.44/Share by Jefferies>HLS.AU NEWS | Sep 25, 2026, 06:37 AM UTC L Novotech Is a CRO and Scientific Advisory Company Backed by TPG, Temasek and GIC Novotech Is a CRO and Scientific Advisory Company Backed by TPG, Temasek and GIC NEWS | Sep 25, 2026, 04:16 AM UTC L Agilex Is a Bioanalytical Laboratory Business Based in Adelaide, Australia Agilex Is a Bioanalytical Laboratory Business Based in Adelaide, Australia NEWS | Sep 25, 2026, 04:16 AM UTC L Novotech: Acquisition Adds Specialist Bioanalytical Expertise in Australia to Asia Network Novotech: Acquisition Adds Specialist Bioanalytical Expertise in Australia to Asia Network MNA | Sep 25, 2026, 04:15 AM UTC L Novotech Reaches Agreement With Healius Subsidiary to Acquire Agilex Biolabs Novotech Reaches Agreement With Healius Subsidiary to Acquire Agilex Biolabs MNA | Sep 25, 2026, 04:14 AM UTC L Novotech To Acquire Agilex Biolabs From Healius Unit Novotech agreed to acquire Agilex Biolabs from a wholly owned subsidiary of Healius Limited, adding bioanalytical labs in Australia to its network. Closing is subject to customary conditions, including regulatory clearan MNA | Sep 25, 2026, 04:12 AM UTC L Healius To Sell Agilex Biolabs To Novotech Healius Limited ASX:HLS NEWS | Sep 25, 2026, 01:28 AM UTC L HLS Therapeutics Increases Normal Course Issuer Bid to 1.9M Shares HLS Therapeutics Increases Normal Course Issuer Bid to 1.9M Shares EQUITY | Sep 24, 2026, 11:08 AM UTC L Healius: Announcement Regards Agilex Biolabs' Sale Process Healius: Announcement Regards Agilex Biolabs' Sale Process NEWS | Sep 23, 2026, 11:45 PM UTC